AYTU BIOPHARMA, INC Research and Development Expense
AYTU BIOPHARMA, INC (AYTU) reported Research and Development Expense of $0 for the 12-month period ending 2026-06-30, per its 10-K filed 2026-09-22.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-09-22
- AYTU BIOPHARMA, INC research and development expense for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- AYTU BIOPHARMA, INC research and development expense for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- AYTU BIOPHARMA, INC research and development expense for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- AYTU BIOPHARMA, INC research and development expense for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- AYTU BIOPHARMA, INC research and development expense for fiscal 2026 was $0.00, a 100.00% decline from fiscal 2025.
- AYTU BIOPHARMA, INC research and development expense for fiscal 2025 was $1.33M, a 52.11% decline from fiscal 2024.
- AYTU BIOPHARMA, INC research and development expense for fiscal 2024 was $2.77M, a 32.38% decline from fiscal 2023.
- AYTU BIOPHARMA, INC research and development expense for fiscal 2023 was $4.09M, a 67.66% decline from fiscal 2022.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-22 | $0.00 derived: sum of 2 quarters · filed 2026-09-22 | $0.00 derived: sum of 3 quarters · filed 2026-09-22 | $0.00 10-K · filed 2026-09-22 | ||||
| 2026-03-31 | $0.00 10-Q · filed 2026-05-13 | $0.00 derived: sum of 2 quarters · filed 2026-05-13 | $0.00 10-Q · filed 2026-05-13 | $216.00K derived: sum of 4 quarters · filed 2026-09-22 | ||||
| 2025-12-31 | $0.00 10-Q · filed 2026-02-03 | $0.00 10-Q · filed 2026-02-03 | $216.00K derived: sum of 3 quarters · filed 2026-09-22 | $378.00K derived: sum of 4 quarters · filed 2026-09-22 | ||||
| 2025-09-30 | $0.00 10-Q · filed 2025-11-13 | $216.00K derived: sum of 2 quarters · filed 2026-09-22 | $378.00K derived: sum of 3 quarters · filed 2026-09-22 | $900.00K derived: sum of 4 quarters · filed 2026-09-22 | ||||
| 2025-06-30 | $216.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-22 | $378.00K derived: sum of 2 quarters · filed 2026-09-22 | $900.00K derived: sum of 3 quarters · filed 2026-09-22 | $1.33M 10-K · filed 2026-09-22 | ||||
| 2025-03-31 | $162.00K 10-Q · filed 2026-05-13 | $684.00K derived: sum of 2 quarters · filed 2026-05-13 | $1.11M 10-Q · filed 2026-05-13 | $2.15M derived: sum of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | $522.00K 10-Q · filed 2026-02-03 | $948.00K 10-Q · filed 2026-02-03 | $1.99M derived: sum of 3 quarters · filed 2026-02-03 | $2.60M derived: sum of 4 quarters · filed 2026-02-03 | ||||
| 2024-09-30 | $426.00K 10-Q · filed 2025-11-13 | $1.47M derived: sum of 2 quarters · filed 2025-11-13 | $2.08M derived: sum of 3 quarters · filed 2025-11-13 | $2.60M derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | $1.04M derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-23 | $1.65M derived: sum of 2 quarters · filed 2025-09-23 | $2.17M derived: sum of 3 quarters · filed 2025-09-23 | $2.77M 10-K · filed 2025-09-23 | $2.79M 10-K · filed 2024-09-26 | |||
| 2024-03-31 | $611.00K 10-Q · filed 2025-05-14 | $619.00K 10-Q · filed 2024-05-15 | $1.13M derived: sum of 2 quarters · filed 2025-05-14 | $1.73M 10-Q · filed 2025-05-14 | $1.75M 10-Q · filed 2024-05-15 | $2.19M derived: sum of 4 quarters · filed 2025-05-14 | ||
| 2023-12-31 | $521.00K 10-Q · filed 2025-02-12 | $524.00K 10-Q · filed 2024-02-14 | $1.12M 10-Q · filed 2025-02-12 | $1.13M 10-Q · filed 2024-02-14 | $1.58M derived: sum of 3 quarters · filed 2025-02-12 | $2.44M derived: sum of 4 quarters · filed 2025-02-12 | ||
| 2023-09-30 | $595.00K 10-Q · filed 2024-11-13 | $604.00K 10-Q · filed 2023-11-14 | $1.06M derived: sum of 2 quarters · filed 2024-11-13 | $1.92M derived: sum of 3 quarters · filed 2024-11-13 | $3.63M derived: sum of 4 quarters · filed 2024-11-13 | |||
| 2023-06-30 | $465.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-26 | $1.32M derived: sum of 2 quarters · filed 2024-09-26 | $3.03M derived: sum of 3 quarters · filed 2024-09-26 | $4.09M 10-K · filed 2024-09-26 | ||||
| 2023-03-31 | $856.00K 10-Q · filed 2024-05-15 | $2.57M derived: sum of 2 quarters · filed 2024-05-15 | $3.63M 10-Q · filed 2024-05-15 | $6.88M derived: sum of 4 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | $1.71M 10-Q · filed 2024-02-14 | $2.77M 10-Q · filed 2024-02-14 | $6.03M derived: sum of 3 quarters · filed 2024-02-14 | $9.31M derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2022-09-30 | $1.06M 10-Q · filed 2023-11-14 | $4.32M derived: sum of 2 quarters · filed 2023-11-14 | $7.60M derived: sum of 3 quarters · filed 2023-11-14 | $12.07M derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | $3.25M derived: 10-K 12 month − 10-Q 9 month · filed 2023-10-12 | $6.54M derived: sum of 2 quarters · filed 2023-10-12 | $11.01M derived: sum of 3 quarters · filed 2023-10-12 | $12.66M 10-K · filed 2023-10-12 | $14.44M 10-K · filed 2022-09-27 | |||
| 2022-03-31 | $3.28M 10-Q · filed 2023-05-11 | $3.73M 10-Q · filed 2022-05-16 | $7.76M derived: sum of 2 quarters · filed 2023-05-11 | $9.41M 10-Q · filed 2023-05-11 | $10.74M 10-Q · filed 2022-05-16 | $14.17M derived: sum of 4 quarters · filed 2023-05-11 | ||
| 2021-12-31 | $4.47M 10-Q · filed 2023-02-21 | $4.92M 10-Q · filed 2022-02-14 | $6.13M 10-Q · filed 2023-02-21 | $7.02M 10-Q · filed 2022-02-14 | $10.89M derived: sum of 3 quarters · filed 2023-02-21 | $11.28M derived: sum of 4 quarters · filed 2023-02-21 | ||
| 2021-09-30 | $1.65M 10-Q/A · filed 2023-02-21 | $2.10M 10-Q · filed 2021-11-15 | $6.42M derived: sum of 2 quarters · filed 2023-02-21 | $6.81M derived: sum of 3 quarters · filed 2023-02-21 | $7.09M derived: sum of 4 quarters · filed 2023-02-21 | |||
| 2021-06-30 | $4.76M derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-27 | $5.15M derived: sum of 2 quarters · filed 2022-09-27 | $5.44M derived: sum of 3 quarters · filed 2022-09-27 | $5.62M 10-K · filed 2022-09-27 | ||||
| 2021-03-31 | $390.00K 10-Q · filed 2022-05-16 | $389.26K 10-Q · filed 2021-05-17 | $676.00K derived: sum of 2 quarters · filed 2022-05-16 | $859.00K 10-Q · filed 2022-05-16 | $858.70K 10-Q · filed 2021-05-17 | $2.36M derived: sum of 4 quarters · filed 2022-05-16 | ||
| 2020-12-31 | $286.00K 10-Q · filed 2022-02-14 | $286.57K 10-Q · filed 2021-02-11 | $469.00K 10-Q · filed 2022-02-14 | $469.44K 10-Q · filed 2021-02-11 | $1.97M derived: sum of 3 quarters · filed 2022-02-14 | $2.05M derived: sum of 4 quarters · filed 2022-02-14 | ||
| 2020-09-30 | $183.00K 10-Q · filed 2021-11-15 | $182.87K 10-Q · filed 2020-11-12 | $1.68M derived: sum of 2 quarters · filed 2021-11-15 | $1.76M derived: sum of 3 quarters · filed 2021-11-15 | $1.83M derived: sum of 4 quarters · filed 2021-11-15 | |||
| 2020-06-30 | $1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-28 | $1.58M derived: sum of 2 quarters · filed 2021-09-28 | $1.64M derived: sum of 3 quarters · filed 2021-09-28 | $1.72M 10-K · filed 2021-09-28 | $1.72M 10-K · filed 2020-10-06 | |||
| 2020-03-31 | $78.50K 10-Q · filed 2021-05-17 | $145.18K derived: sum of 2 quarters · filed 2021-05-17 | $223.20K 10-Q · filed 2021-05-17 | $398.46K derived: sum of 4 quarters · filed 2021-05-17 | ||||
| 2019-12-31 | $66.67K 10-Q · filed 2021-02-11 | $144.69K 10-Q · filed 2021-02-11 | $319.96K derived: sum of 3 quarters · filed 2021-02-11 | $428.86K derived: sum of 4 quarters · filed 2021-02-11 | ||||
| 2019-09-30 | $78.02K 10-Q · filed 2020-11-12 | $253.28K derived: sum of 2 quarters · filed 2020-11-12 | $362.19K derived: sum of 3 quarters · filed 2020-11-12 | $511.21K derived: sum of 4 quarters · filed 2020-11-12 | ||||
| 2019-06-30 | $175.26K derived: 10-K 12 month − 10-Q 9 month · filed 2020-10-06 | $284.17K derived: sum of 2 quarters · filed 2020-10-06 | $433.19K derived: sum of 3 quarters · filed 2020-10-06 | $589.07K 10-K · filed 2020-10-06 | ||||
| 2019-03-31 | $108.90K 10-Q · filed 2020-05-15 | $257.93K derived: sum of 2 quarters · filed 2020-05-15 | $413.81K 10-Q · filed 2020-05-15 | $603.79K derived: sum of 4 quarters · filed 2020-05-15 | ||||
| 2018-12-31 | $149.03K 10-Q · filed 2020-02-14 | $304.91K 10-Q · filed 2020-02-14 | $494.89K derived: sum of 3 quarters · filed 2020-02-14 | $609.03K derived: sum of 4 quarters · filed 2020-02-14 | ||||
| 2018-09-30 | $155.88K 10-Q · filed 2019-11-14 | $345.86K derived: sum of 2 quarters · filed 2019-11-14 | $460.00K derived: sum of 3 quarters · filed 2019-11-14 | $182.52K derived: sum of 4 quarters · filed 2019-11-14 | ||||
| 2018-06-30 | $189.99K derived: 10-K 12 month − 10-Q 9 month · filed 2019-09-26 | $304.13K derived: sum of 2 quarters · filed 2019-09-26 | $26.64K derived: sum of 3 quarters · filed 2019-09-26 | $167.59K 10-K · filed 2019-09-26 | ||||
| 2018-03-31 | $114.14K 10-Q · filed 2019-05-14 | -$163.34K derived: sum of 2 quarters · filed 2019-05-14 | -$22.39K 10-Q · filed 2019-05-14 | $162.94K derived: sum of 4 quarters · filed 2019-05-14 | ||||
| 2017-12-31 | -$277.49K 10-Q · filed 2019-05-14 | -$136.53K 10-Q · filed 2019-05-14 | $48.80K derived: sum of 3 quarters · filed 2019-05-14 | $327.85K derived: sum of 4 quarters · filed 2019-05-14 | ||||
| 2017-09-30 | $140.95K 10-Q · filed 2018-11-07 | $326.29K derived: sum of 2 quarters · filed 2018-11-07 | $605.33K derived: sum of 3 quarters · filed 2018-11-07 | $868.79K derived: sum of 4 quarters · filed 2018-11-07 | ||||
| 2017-06-30 | $185.33K derived: 10-K 12 month − 10-Q 9 month · filed 2018-09-06 | $464.38K derived: sum of 2 quarters · filed 2018-09-06 | $727.84K derived: sum of 3 quarters · filed 2018-09-06 | $959.86K 10-K · filed 2018-09-06 | ||||
| 2017-03-31 | $279.05K 10-Q · filed 2018-05-14 | $542.51K derived: sum of 2 quarters · filed 2018-05-14 | $774.53K 10-Q · filed 2018-05-14 | $3.59M derived: sum of 4 quarters · filed 2018-05-14 | ||||
| 2016-12-31 | $263.46K 10-Q · filed 2018-02-08 | $495.48K 10-Q · filed 2018-02-08 | $3.32M derived: sum of 3 quarters · filed 2018-02-08 | $4.46M derived: sum of 4 quarters · filed 2018-02-08 | ||||
| 2016-09-30 | $232.02K 10-Q · filed 2017-11-09 | $3.05M derived: sum of 2 quarters · filed 2017-11-09 | $4.20M derived: sum of 3 quarters · filed 2017-11-09 | $5.50M derived: sum of 4 quarters · filed 2017-11-09 | ||||
| 2016-06-30 | $2.82M derived: 10-K 12 month − 10-Q 9 month · filed 2017-08-31 | $3.96M derived: sum of 2 quarters · filed 2017-08-31 | $5.27M derived: sum of 3 quarters · filed 2017-08-31 | $6.13M 10-K · filed 2017-08-31 | ||||
| 2016-03-31 | $1.14M 10-Q · filed 2017-05-11 | $2.45M derived: sum of 2 quarters · filed 2017-05-11 | $3.31M 10-Q · filed 2017-05-11 | $4.11M derived: sum of 4 quarters · filed 2017-05-11 | ||||
| 2015-12-31 | $1.31M 10-Q · filed 2017-02-09 | $2.16M 10-Q · filed 2017-02-09 | $2.97M derived: sum of 3 quarters · filed 2017-02-09 | $3.66M derived: sum of 4 quarters · filed 2017-02-09 | ||||
| 2015-09-30 | $855.87K 10-Q · filed 2016-11-07 | $1.66M derived: sum of 2 quarters · filed 2016-11-07 | $2.35M derived: sum of 3 quarters · filed 2016-11-07 | $3.14M derived: sum of 4 quarters · filed 2016-11-07 | ||||
| 2015-06-30 | $801.24K derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-01 | $1.50M derived: sum of 2 quarters · filed 2016-09-01 | $2.29M derived: sum of 3 quarters · filed 2016-09-01 | $3.22M 10-K · filed 2016-09-01 | ||||
| 2015-03-31 | $694.18K 10-Q · filed 2016-05-11 | $1.48M derived: sum of 2 quarters · filed 2016-05-11 | $2.42M 10-Q · filed 2016-05-11 | $3.71M derived: sum of 4 quarters · filed 2016-05-11 | ||||
| 2014-12-31 | $789.97K 10-Q · filed 2016-02-11 | $1.72M 10-Q · filed 2016-02-11 | $3.02M derived: sum of 3 quarters · filed 2016-02-11 | $4.25M derived: sum of 4 quarters · filed 2016-02-11 | ||||
| 2014-09-30 | $933.75K 10-Q · filed 2015-11-06 | $2.23M derived: sum of 2 quarters · filed 2015-11-06 | $3.46M derived: sum of 3 quarters · filed 2015-11-06 | |||||
| 2014-06-30 | $1.29M derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-28 | $2.53M derived: sum of 2 quarters · filed 2015-09-28 | $3.93M 10-K · filed 2015-09-28 | |||||
| 2014-03-31 | $1.24M 10-Q · filed 2015-05-19 | $2.64M 10-Q · filed 2015-05-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |